Lifestyle
Camizestrant Etcamah FDA Nod Moves Failure Earlier. Confirmatory Trials Must Prove Patients Gain.
FDA's camizestrant approval lets doctors switch breast cancer therapy on a blood test, before scans show the disease is growing.
FDA's camizestrant approval lets doctors switch breast cancer therapy on a blood test, before scans show the disease is growing.